New research suggests that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who stop traditional diet and exercise plans.
Research printed in a leading health publication demonstrates that while overweight people often shed about a fifth of their body weight while on the medication, the mass is regained at an average rate of 0.8 kg per month after stopping.
"People purchasing such treatments need to be cognizant of the potential of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
This pace of regain implies a return to original mass within about 18 months.
Comparing Treatments
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with older methods.
The team note that people who shed pounds through lifestyle changes alone usually have a slower weight regain—approximately 100 grams monthly—after stopping.
Understanding the Quick Regain
Doctors propose the mechanism of the injections is key to understanding the amplified weight return.
The injections mimic a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 levels far above than normal might result in the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication means hunger is no longer kept in check, making binge eating a significant risk."
A Chronic Condition?
The NHS recommend the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals argue that, given the significant potential of relapse, the treatment might need to be life-long.
This view is reinforced by pharmaceutical companies, who note that the results "underscore the long-term nature of excess weight," comparing it to managing conditions like hypertension.
User Testimonies
Users who have stopped the jabs describe a intense resurgence of cravings.
"I experienced a switch that goes on and you become starving," described one woman.
This difficulty is compounded if users have not established sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.
- Use is higher among females compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, researchers caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on integrated behavioural changes.